User profiles for Cathy Davies

Cathy Davies

Institute of Psychiatry, King's College London
Verified email at kcl.ac.uk
Cited by 3150

What causes psychosis? An umbrella review of risk and protective factors

…, T Amir, H Yenn Thoo, D Oliver, C Davies… - World …, 2018 - Wiley Online Library
Psychosis is a heterogeneous psychiatric condition for which a multitude of risk and
protective factors have been suggested. This umbrella review aimed to classify the strength of …

Transdiagnostic psychiatry: a systematic review

P Fusar‐Poli, M Solmi, N Brondino, C Davies… - World …, 2019 - Wiley Online Library
The usefulness of current psychiatric classification, which is based on ICD/DSM categorical
diagnoses, remains questionable. A promising alternative has been put forward as the “…

Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis

C Davies, G Segre, A Estradé, J Radua… - The Lancet …, 2020 - thelancet.com
Background Prenatal and perinatal insults are implicated in the aetiopathogenesis of psychotic
disorders but the consistency and magnitude of their associations with psychosis have …

Development and validation of a clinically based risk calculator for the transdiagnostic prediction of psychosis

P Fusar-Poli, G Rutigliano, D Stahl, C Davies… - JAMA …, 2017 - jamanetwork.com
Importance The overall effect of At Risk Mental State (ARMS) services for the detection of
individuals who will develop psychosis in secondary mental health care is undetermined. …

Lack of evidence to favor specific preventive interventions in psychosis: a network meta‐analysis

C Davies, A Cipriani, JPA Ioannidis, J Radua… - World …, 2018 - Wiley Online Library
Preventing psychosis in patients at clinical high risk may be a promising avenue for pre‐emptively
ameliorating outcomes of the most severe psychiatric disorder. However, information …

Cannabis-associated psychosis: Neural substrate and clinical impact

…, A Abi-Dargham, DA Lewis, M Di Forti, C Davies… - …, 2017 - Elsevier
Prospective epidemiological studies have consistently demonstrated that cannabis use is
associated with an increased subsequent risk of both psychotic symptoms and schizophrenia-…

What causes the onset of psychosis in individuals at clinical high risk? A meta-analysis of risk and protective factors

…, O Baccaredda Boy, N Petros, C Davies… - Schizophrenia …, 2020 - academic.oup.com
Twenty percent of individuals at clinical high risk for psychosis (CHR-P) develop the disorder
within 2 years. Extensive research has explored the factors that differentiate those who …

Can we reduce the duration of untreated psychosis? A systematic review and meta-analysis of controlled interventional studies

D Oliver, C Davies, G Crossland, S Lim… - Schizophrenia …, 2018 - academic.oup.com
Reduction of duration of untreated psychosis (DUP) is the key strategy of early interventions
for improving the outcomes of first-episode psychosis. Although several controlled …

Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders

P Fusar-Poli, G Rutigliano, D Stahl, C Davies… - European …, 2017 - cambridge.org
BackgroundThe long-term clinical validity of the At Risk Mental State (ARMS) for the prediction
of non-psychotic mental disorders is unknown.MethodsClinical register-based cohort …

Cannabidiol as a potential treatment for psychosis

C Davies, S Bhattacharyya - Therapeutic advances in …, 2019 - journals.sagepub.com
Psychotic disorders such as schizophrenia are heterogeneous and often debilitating
conditions that contribute substantially to the global burden of disease. The introduction of …